Immunotherapy for Metastatic Kidney Cancer Shows Increased Survival
2 Bekeken
administrator
07/10/23
The immune checkpoint inhibitor Opdivo (nivolumab) has been shown to increase survival for patients with metastatic clear cell kidney cancer (also called renal cell carcinoma, or RCC).
Laat meer zien
Facebook Reacties
Geen reacties gevonden